How Teva Turned Olanzapine.com Into a High-Visibility Search Asset
Teva Pharmaceuticals acquired the exact-match Olanzapine.com domain in November 2024 and began developing the website in 2025.
By 2026, the site had built 400K+ search impressions, 200+ ranking keywords and 20+ top-three Google positions.
The domain directly matches a medicine in Teva’s generics business
Teva has a substantial presence in generic medicines and describes itself as a leading provider of generic drugs in the United States.
Its U.S. generics portfolio includes approximately 500 medicines across major therapeutic categories.
Olanzapine is one of those medicines. Teva markets Olanzapine Orally Disintegrating Tablets, USP in the United States.
That makes Olanzapine.com unusually relevant: the website address is the exact generic name of a medicine the company actually supplies.
Olanzapine
Teva lists olanzapine orally disintegrating tablets in the atypical antipsychotics category, with Zyprexa® Zydis® identified as the brand equivalent.
From domain name to active pharmaceutical website
From acquisition to significant search visibility
Teva acquires the exact-match Olanzapine.com domain.
The previously undeveloped domain becomes an active web property focused on olanzapine.
The site reaches hundreds of thousands of impressions and begins ranking prominently across relevant searches.
A significant organic footprint built in a relatively short period
The supplied SEO data shows Olanzapine.com progressing from negligible visibility in 2025 to more than 400,000 search impressions.
By September 2026, the site was visible for approximately 200+ keywords within Google’s top 50, including more than 20 keywords in the top three positions.
At its peak during the period shown, the site reached approximately 32 top-three rankings.
The strength of the asset is the alignment
An exact-match domain does not automatically create Google rankings. Content quality, technical implementation, authority, competition and many other factors influence organic search performance.
What makes the Teva example compelling is the direct connection between the company, the medicine and the domain.
A pharmaceutical domain can become more than a defensive asset
Teva did not simply acquire Olanzapine.com and leave it unused. The company turned the domain into an active website centered on a medicine directly relevant to its business.
The subsequent search growth demonstrates the potential of combining a highly relevant pharmaceutical domain with active development and useful content.
More than 240 premium generic-drug .com domains
DigitalGenerics specializes in premium .com domains connected to generic medicines.
The portfolio was built over decades and gives pharmaceutical companies the opportunity to acquire the exact-match .com corresponding to medicines relevant to their businesses.
Does DigitalGenerics own the .com for one of your medicines?
Explore more than 240 premium generic-drug domain names and see which exact-match .com domains are currently available.